Jupiter Life Line Hospitals Ltd vs Max Healthcare Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Jupiter Life Line Hospitals Ltd is ₹ 256.3 as of 30 Oct 15:30 . The P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 43 on March 2026 . This represents a CAGR of -1.14% over 3 yearsThe P/E Ratio of Max Healthcare Institute Ltd changed from 55.6 on March 2022 to 64.9 on March 2026 . This represents a CAGR of 3.14% over 5 years The Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 8344 crore on March 2026 . This represents a CAGR of 2.04% over 3 yearsThe Market Cap of Max Healthcare Institute Ltd changed from ₹ 19903 crore on March 2021 to ₹ 93581 crore on March 2026 . This represents a CAGR of 29.43% over 6 years The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The revenue of Max Healthcare Institute Ltd for the Sep '26 is ₹ 2610 crore as compare to the Jun '26 revenue of ₹ 2406 crore. This represent the growth of 8.45% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The ebitda of Max Healthcare Institute Ltd for the Sep '26 is ₹ 752.39 crore as compare to the Jun '26 ebitda of ₹ 638.97 crore. This represent the growth of 17.75% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The net profit of Max Healthcare Institute Ltd changed from ₹ 236.27 crore to ₹ 414.45 crore over 10 quarters. This represents a CAGR of 25.21% The Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 yearsThe Dividend Payout of Max Healthcare Institute Ltd changed from 13.98 % on March 2023 to 27.16 % on March 2026 . This represents a CAGR of 18.06% over 4 years .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the 'Jupiter' brand.
The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds.
The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare.

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001.
Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'.
Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'.
The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspecialty Hospitals facilities. The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 22 network healthcare facilities, which includes BLK Hospital and BNH Hospital.

FAQs for the comparison of Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd

Which company has a larger market capitalization, Jupiter Life Line Hospitals Ltd or Max Healthcare Institute Ltd?

Market cap of Jupiter Life Line Hospitals Ltd is 8,402 Cr while Market cap of Max Healthcare Institute Ltd is 83,704 Cr

What are the key factors driving the stock performance of Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd?

The stock performance of Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd?

As of October 31, 2026, the Jupiter Life Line Hospitals Ltd stock price is INR ₹256.3. On the other hand, Max Healthcare Institute Ltd stock price is INR ₹860.0.

How do dividend payouts of Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd compare?

To compare the dividend payouts of Jupiter Life Line Hospitals Ltd and Max Healthcare Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.